King's College London British Heart Foundation Centre of Excellence, London, UK.
Lancet. 2011 Aug 20;378(9792):704-12. doi: 10.1016/S0140-6736(11)60894-5.
Chronic heart failure continues to impose a substantial health-care burden, despite recent treatment advances. The key pathophysiological process that ultimately leads to chronic heart failure is cardiac remodelling in response to chronic disease stresses. Here, we review recent advances in our understanding of molecular and cellular mechanisms that play a part in the complex remodelling process, with a focus on key molecules and pathways that might be suitable targets for therapeutic manipulation. Such pathways include those that regulate cardiac myocyte hypertrophy, calcium homoeostasis, energetics, and cell survival, and processes that take place outside the cardiac myocyte--eg, in the myocardial vasculature and extracellular matrix. We also discuss major gaps in our current understanding, take a critical look at conventional approaches to target discovery that have been used to date, and consider new investigational avenues that might accelerate clinically relevant discovery.
慢性心力衰竭尽管在最近的治疗进展后仍继续造成重大的医疗保健负担。最终导致慢性心力衰竭的关键病理生理过程是心脏对慢性疾病压力的重塑。在这里,我们回顾了对在复杂重塑过程中起作用的分子和细胞机制的最新理解,重点介绍了可能适合治疗干预的关键分子和途径。这些途径包括调节心肌细胞肥大、钙稳态、能量代谢和细胞存活的途径,以及发生在心肌细胞之外的过程,例如心肌血管和细胞外基质。我们还讨论了我们目前理解中的主要差距,批判性地审视了迄今为止用于发现靶点的传统方法,并考虑了可能加速具有临床相关性发现的新研究途径。